MedTrace Logo

Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery

NCT05234658 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2023-11-08

No results posted yet for this study

Summary

Phase II Clinical Trial Evaluating the Safety and Efficacy of a Tissue Engineered Autologous Skin Substitute Reconstructive Surgery for Basal Cell Carcinoma

Conditions

Interventions

BIOLOGICAL

PHITAH

Tissue Engineered Human Artificial Skin: Fibrin-Hyaluronic Acid

BIOLOGICAL

PHIT

Human artificial skin created by tissue engineering: fibrin-agarose

BIOLOGICAL

Skin Autograft

Skin Autograft

Sponsors & Collaborators

  • Andalusian Network for Design and Translation of Advanced Therapies

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-21
Primary Completion
2024-01-01
Completion
2024-12-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05234658 on ClinicalTrials.gov